Abvc Biopharma (ABVC) Debt Ratio (2010 - 2026)

Abvc Biopharma (ABVC) has reported Debt Ratio for 15 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Debt Ratio fell 97.3% year-over-year to 0.01; the trailing twelve-month figure through Jun 2026 stood at 0.01 (down 97.3% YoY), and the FY2025 full-year result was 0.07, down 67.81% from the prior year.
• Debt Ratio retreated to 0.01 in Q2 2026 per ABVC's latest filing, from 0.01 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.4 in Q4 2022 and bottomed at 0.01 in Q2 2026.
• Historically, Debt Ratio has averaged 0.16 across 5 years, with a median of 0.16 in 2022.
• The sharpest annual moves came in 2024 and 2026: Debt Ratio jumped 156.87% in 2024, then slumped 97.3% in 2026.
• Over 5 years, Debt Ratio stood at 0.4 in 2022, then tumbled by 41.56% to 0.23 in 2023, then decreased by 3.53% to 0.22 in 2024, then slumped by 67.81% to 0.07 in 2025, then tumbled by 91.46% to 0.01 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.01, 0.01, and 0.07 for Q2 2026, Q1 2026, and Q4 2025 respectively.